Skip to content

A randomized controlled trial of modified cocktail formulation on analgesia and early functional recovery after TKA

A randomized controlled trial of modified cocktail formulation on analgesia and early functional recovery after TKA

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055981
Enrollment
Unknown
Registered
2022-01-30
Start date
2022-02-09
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee

Interventions

Group C:Periarticular local infiltrating drug (cocktail) consists of ropivacaine + epinephrine + dexamethasone + magnesium sulfate
Group D:Periarticular local infiltrating drug (cocktail) consists of ropivacaine + epinephrine + dexamethasone + sodium bicarbonate

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients requiring unilateral initial TKA surgery due to severe knee osteoarthritis; 2. Aged 18 to 80 years; 3. The American Society of Anesthesiologists (ASA) classification (anesthesia risk assessment) is I - III level.

Exclusion criteria

Exclusion criteria: 1. Allergic to anesthetic drugs and sulfa; 2. There were more than moderate intraoperative knee malformations (pronation and flexion malformations) and joint stiffness; 3. Alcoholic or long-term opioid users; 4. Language impairment and inability to perform pain numerical scales (NRS); 5. Surgical limb neuropathy; 6. Mental patients; 7. Patients with previous gastrointestinal ulcer.

Design outcomes

Primary

MeasureTime frame
Time to first postoperative remedial analgesia;Postoperative dosage of remedial morphine hydrochloride;

Secondary

MeasureTime frame
VAS pain score;Range of knee motion;Quadriceps strength;Incidence of postoperative complications;Daily walking distance;The duration of hospital stay;Inflammatory indicators;

Countries

China

Contacts

Public ContactKang Pengde

West China Hospital, Sichuan University

kangpd@163.com+86 18280213153

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026